Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DeLong

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 5, 2023
Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid ConjugatesJill Sturdivant, Stuart S Williams, Maria Ina, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
Biochemistry|March 17, 1999
N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amidesB J Wilcox, K J Ritenour-Rodgers, A S Asser, et al.
Journal of Medicinal Chemistry|November 16, 2001
Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosisD L Soper, J B Milbank, G E Mieling, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 5, 2023
Discovery and Preclinical Development of Novel Intraocular Pressure-Lowering Rho Kinase Inhibitor: Corticosteroid ConjugatesJill Sturdivant, Stuart S Williams, Maria Ina, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
Biochemistry|March 17, 1999
N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amidesB J Wilcox, K J Ritenour-Rodgers, A S Asser, et al.
Journal of Medicinal Chemistry|November 16, 2001
Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosisD L Soper, J B Milbank, G E Mieling, et al.
Pageof 8